⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12687558 | 1.00 | — | — | |
| SCHEMBL12093049 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL744751 | 0.97 | MAPK1 (0.33) | — | |
| SCHEMBL15467260 | 0.88 | MAPK1 (0.42) | — | |
| SCHEMBL852389 | 0.88 | MAPK1 (0.48) | — | |
| SCHEMBL11240031 | 0.86 | — | — | |
| SCHEMBL2210250 | 0.86 | MAPK1 (0.32) | — | |
| SCHEMBL2079914 | 0.73 | CHRNB2 (0.38) | — | |
| SCHEMBL8134094 | 0.73 | ALDH1A1 (0.30) | — | |
| SCHEMBL1847929 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3681875-B1 | CYCLIC PEPTIDE ANTIBIOTICS | HOFFMANN LA ROCHE (CH) | 2026-01-14 | — | — | EP | disclosed |
| US-12358887-B2 | IKAROS Zinc Finger Family degraders and uses thereof | GILEAD SCIENCES, INC. (US) | 2025-07-15 | — | — | US | disclosed |
| US-12358951-B2 | Cyclic peptide antibiotics | GENENTECH, INC. (US) | 2025-07-15 | — | — | US | disclosed |
| CN-111148739-B | Cyclic peptide antibiotics | 豪夫迈·罗氏有限公司 | 2025-06-03 | — | — | CN | disclosed |
| US-20250171431-A1 | HETEROCYCLIC INHIBITORS OF IGF-1R FOR TREATMENT OF DISEASE | HORIZON THERAPEUTICS IRELAND DAC (IE) | 2025-05-29 | — | — | US | disclosed |
| WO-2025030163-A1 | HETEROCYCLIC INHIBITORS OF IGF-1R FOR TREATMENT OF DISEASE | HORIZON THERAPEUTICS IRELAND DAC (IE) | 2025-02-06 | — | — | WO | disclosed |
| EP-4464703-A2 | IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF | Gilead Sciences, Inc. (US) | 2024-11-20 | — | — | EP | disclosed |
| EP-4245756-B1 | IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF | GILEAD SCIENCES INC (US) | 2024-10-09 | — | — | EP | disclosed |
| US-11897862-B2 | IKAROS zinc finger family degraders and uses thereof | GILEAD SCIENCES, INC. (US) | 2024-02-13 | — | — | US | disclosed |
| US-20230373989-A1 | N-PHENYLAMINOCARBONYL PYRIDINO-, PYRIMIDINO AND BENZO-TROPANES AS MODULATORS OF GPR65 | Pathios Therapeutics Limited (GB) | 2023-11-23 | — | — | US | disclosed |
| WO-2002088130-A1 | AZABICYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-[2,3-F]QUINOLINE AS 5-HT1A ANTAGONISTS | WYETH (US) | 2002-11-07 | — | — | WO | disclosed |
| US-6348183-B2 | A ZEOLITE HAVING A MOLE RATIO GREATER THAN ABOUT 20 OF AN OXIDE OF A FIRST TETRAVALENT ELEMENT TO AN OXIDE OF A SECOND TETRAVALENT ELEMENT DIFFERENT FROM FIRST TETRAVALENT, TRIVALENT, PENTAVALENT ELEMENTS; USES BICYCLO AMMONIUM CATION | CHEVRON U.S.A., INC. | 2002-02-19 | — | — | US | disclosed |
| US-20010027935-A1 | Zeolite SSZ-47 | LEE GREGORY S (US) | 2001-10-11 | — | — | US | disclosed |
| EP-0952962-B1 | ZEOLITE SSZ-47 | CHEVRON USA INC (US) | 2001-10-10 | — | — | EP | disclosed |
| US-20010000323-A1 | Zeolite SSZ-47 | LEE GREGORY S (US) | 2001-04-19 | — | — | US | disclosed |
| US-6156290-A | Zeolite SSZ-47 | CHEVRON U.S.A. INC. (US) | 2000-12-05 | — | — | US | disclosed |
| EP-0952962-A1 | ZEOLITE SSZ-47 | CHEVRON U.S.A. INC. (US) | 1999-11-03 | — | — | EP | disclosed |
| WO-1998029337-A1 | ZEOLITE SSZ-47 | CHEVRON U.S.A. INC. (US) | 1998-07-09 | — | — | WO | disclosed |
| EP-0334477-A2 | Novel photoactive compounds, processes for their production and intermediates therefor | MTM RESEARCH CHEMICALS LIMITED (GB) | 1989-09-27 | — | — | EP | disclosed |
| US-4812567-A | ANXIOLYTIC AGENTS, ANTIPSYCHOTIC | AMERICAN HOME PRODUCTS CORPORATION (US) | 1989-03-14 | — | — | US | disclosed |